Added to YB: 2024-08-09
Pitch date: 2024-08-08
FNCH [bullish]
Finch Therapeutics Group, Inc.
+201.28%
current return
Author Info
Multibagger Monitor focuses on event-driven, reflexive, and microcap situations with the potential to appreciate rapidly in <2 years. Sign up for the newsletter.
Company Info
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.
Market Cap
$19.3M
Pitch Price
$4.00
Price Target
N/A
Dividend
N/A
Sector
Biotechnology
Category
special_situation
Intriguing Patent Litigation Situation - $FNCH
FNCH: Patent litigation vs Ferring on FMT tech. Verdict due tomorrow. $5M mkt cap, $15M+ cash. If win, potential 30% royalty on Rebyota ($40M+ sales). Seeking $50M+ damages + 30% ongoing royalty. Risks: Prior art invalidation, cash burn on legal fees. Recent positive developments: Ferring stipulates FNCH patent ownership, judge displeased w/ Ferring behavior. Binary outcome.
Read full article (4 min)